{{cart_num}}
My CartCAS：442-51-3
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：Off-white to brown Solid
Qty：
Size：
| CAS | 442-51-3 |
| Name | Harmine |
| Molecular Formula | C13H12N2O |
| Molecular Weight | 212.25 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | Off-white to brown Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 207-131-4 |
| MDL | MFCD00004958 |
| SMILES | CC1=NC=CC2=C1NC3=C2C=CC(OC)=C3 |
| InChIKey | BXNJHAXVSOCGBA-UHFFFAOYSA-N |
| InChI | InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3 |
| PubChem CID | 5280953 |
| Target Point | DYRK;PPARγ;5-HT Receptor;MAO-A |
| Passage | Cell Cycle;DNA Damage/DNA Repair;Metabolic Enzyme&Protease;Neuronal Signaling;GPCR & G Protein;Protein Tyrosine Kinase/RTK |
| Background | It is a bi-specific tyrosine phosphorylated regulated kinase (DYRK) inhibitor with anti-cancer and anti-inflammatory activities. It has a high affinity for 5-HT2A serotonin receptor. PPARγ expression is regulated by inhibition of Wnt signaling pathway. It also selectively binds MAO-A and reversibly inhibits it. |
| Biological Activity | Harmine是5-HT2A的抑制剂，Ki为397 nM [1]。 |
| In Vitro | Harmine通过选择的DANDY抑制DYRK1A的tau磷酸化，IC50为190 nM [2] .Harmine通过干扰Rad51募集负调节HR，导致肝癌细胞的严重细胞毒性。此外，NHEJ抑制剂Nu7441显著增强Hep3B细胞对Harmine的抗增殖作用[3]。 |
| In Vivo | 结果表明，TBI组脑水含量显著增加。与TBI组相比，Harmine治疗在第1，3和5天显著降低组织水含量。与TBI组相比，Harmine治疗显著降低了3天和5天的逃避潜伏期。与没有Harmine治疗的TBI组相比，TBI后TBI给予显著改善TBI后1，3和5天大鼠的运动功能恢复。与TBI组相比，Harmine治疗组的神经元存活率显著增加。与TBI组相比，给予Harmine导致GLT-1表达显著升高。与TBI组相比，Harmine的给药显著降低了caspase 3的表达[4]。 |
| Animal Experiment | 大鼠[4]共150只雄性Sprague-Dawley大鼠(年龄10-12周;体重280-320g;用于本研究。大鼠随机分为三组：假手术组(假手术组); n = 15); TBI组(TBI; n = 35)和TBI + Harmine治疗组(Harmine; n = 35)。在TBI(ip，30 mg/kg/d)后立即给予Harmine用于向上假性和TBI组接受等体积的0.9％生理盐水(ip)。大鼠按如下分组进行行为恢复检查：Sham，n = 3; TBI，n = 7;和Harmine，n = 7.在TBI后，在第1，3和5天评估NSS。每只大鼠由对动物治疗不知情的观察者进行评估[4]。 |
| Data Literature Source | [1]. Glennon RA，et al. Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A))，dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend. 2000 Aug 1;60(2):121-32. [2]. Neumann F，et al. DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives. Sci Rep. 2018 Feb 12;8(1):2859. [3]. Zhang L，et al. Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells. Cancer Biol Ther. 2015;16(11):1585-92. [4]. Zhong Z，et al. Treatment with harmine ameliorates functional impairment and neuronal death following traumatic brain injury. Mol Med Rep. 2015 Dec;12(6):7985-91. |
| Unit | Bottle |
| Specification | 20mg 10mM*1mL in DMSO 100mg |
是一种具有抗癌和抗炎活性的双特异性酪氨酸磷酸化调节激酶 ((DYRK)) 抑制剂。对 5-HT2A 血清素受体具有高亲和力。通过抑制 Wnt 信号通路来调节 PPARγ 的表达。 还选择性地结合 MAO-A 并可逆地抑制单胺氧化酶 A (MAO-A)。
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Manual Download
